A.R.T. Advisors’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

A.R.T. Advisors’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13,455	Closed	-$8K	–	1823
2018 Q4	$8K	Sell	13,455 -3,888	-22%	-$4.04K	﹤0.01%	1267
2018 Q3	$22K	Buy	+17,343	New	+$26.9K	﹤0.01%	1343
2018 Q2	–	Sell	-48,692	Closed	-$70K	–	2006
2018 Q1	$70K	Buy	+48,692	New	+$102K	﹤0.01%	1381
2015 Q3	–	Sell	-19,216	Closed	-$88K	–	1870
2015 Q2	$88K	Buy	+19,216	New	+$184K	﹤0.01%	1380

A.R.T. Advisors's AST Position: Q1 2019 in Review

A.R.T. Advisors sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 13,455 shares — an estimated $8K sold.

A.R.T. Advisors first reported a position in AST in Q2 2015 and held it in 4 quarters. The position peaked at $88K in Q2 2015. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

A.R.T. Advisors reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
A.R.T. Advisors sold 13,455 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $8K.
A.R.T. Advisors first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2015 and held it in 4 quarters.
A.R.T. Advisors's Asterias Biotherapeutics Inc. Series A position peaked at $88K in Q2 2015.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.